E-DRUG: Jan 18 Hearing on TRIPS and Access to Meds in the EU Parliament
-----------------------------------------------------------------------
[Note that if you want to assist to the hearing, you need to contact the INTA
Committee Secretariat [xp-inta@europarl.eu.int] and ask for a pass to enter the
building. SG]
EUROPEAN PARLIAMENT
COMMITTEE ON INTERNATIONAL TRADE
HEARING ON TRIPS AND ACCESS TO MEDICINES
on Tuesday, 18 January 2005, at 9.00 a.m. - 12.30 p.m.
Hemicycle - Brussels
PROGRAMME
9.00 - 9.15
Opening of the Hearing by Enrique Barsn Crespo, Chairman of the Committee on
International Trade
9.15-9.25
Presentation by Roger Kampf, Counsellor, Intellectual Property Division,
World Trade Organisation
9.25-9.35
Presentation by Ellen F.M. 't Hoen LL.M., Director policy advocacy and
research, Midicins Sans Frontihres, Access to Essential Medicines Campaign
9.35 - 10.15
Questions and comments by members
10.15-10.20
Presentation by Brian Ager, Director General of the European Federation of
Pharmaceutical Industries and Associations (EFPIA)
10.20-10.25
Presentation by William F. Haddad, Chairman/CEO of the Generic
Pharmaceutical Industry Association, representing Cipla, Ltd. (India)
10.25-11.15
Questions and comments by members
11.15-11.25
Presentation by Maigari Gurama Buba, Second Secretary, Nigeria Trade Office
to the WTO
11.25-11.35
Presentation by Francisco Pessanha Cannabrava, Head of Trade Sector, Embassy
of Brazil to Mexico
11.35-12.15
Questions and comments by members
12.15-12.30
Conclusions
---
Seco Gerard
MSF Access Campaign EU Liaison Officer
C/O MSF Belgium
Rue Dupri 94
1090 Brussels
Direct number: +32 2 474 75 09
Fax number: +32 2 474 75 75
Mobile number: +32 479 514 900
|